The Endocannabinoid System in Human Gestational Tissues in Labor



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:2/22/2019
Start Date:January 25, 2019
End Date:May 2019
Contact:Melissa L Kozakiewicz, MD
Email:mkozakie@wakehealth.edu
Phone:336-716-6289

Use our guide to learn which trials are right for you!

The purpose of this research study is to determine if the endocannabinoid (a biological
system) plays a role in the labor process.

This is a pilot study to determine the feasibility of identification and quantification of
various components of the endocannabinoid system in the labored versus non-labored
myometrium, placenta and gestational membranes.

Inclusion Criteria:

- Pregnant women ages > 18 years old

- Pregnant women 22 weeks, 0 days through 42 weeks, 0 days gestation undergoing cesarean
section

- Singleton gestation

Exclusion Criteria:

- Cannabinoid use during pregnancy

- Illicit drug use during pregnancy

- Nonsteroidal anti-inflammatory drug use within 7 days of cesarean section

- Maternal comorbidities including pre-existing diabetes, pre-existing hypertension,
hypertensive disorders of pregnancy (preeclampsia, eclampsia), epilepsy currently
being treated with antiepileptic medication, intraamniotic infection

- Uterine abnormalities

- Fetal anomalies

- Drug use or dependency
We found this trial at
2
sites
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
336-716-2011
Principal Investigator: Melissa L Kozakiewicz, MD
Phone: 336-716-6289
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Winston-Salem, North Carolina 27103
Principal Investigator: Melissa L Kozakiewicz, MD
Phone: 336-716-6289
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials